-----BEGIN PRIVACY-ENHANCED MESSAGE-----
Proc-Type: 2001,MIC-CLEAR
Originator-Name: webmaster@www.sec.gov
Originator-Key-Asymmetric:
 MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen
 TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB
MIC-Info: RSA-MD5,RSA,
 J6OJxxLl88XaUrL4fHQffDK3e9WQ+QCYFCEQz6PmHCN2dUwGpnoRaGPX4sLqQv09
 vw5ucR5rT91YNhz2EhdUlg==

<SEC-DOCUMENT>0000927946-04-000205.txt : 20040921
<SEC-HEADER>0000927946-04-000205.hdr.sgml : 20040921
<ACCEPTANCE-DATETIME>20040921172215
ACCESSION NUMBER:		0000927946-04-000205
CONFORMED SUBMISSION TYPE:	10-K/A
PUBLIC DOCUMENT COUNT:		4
CONFORMED PERIOD OF REPORT:	20030930
FILED AS OF DATE:		20040921
DATE AS OF CHANGE:		20040921

FILER:

	COMPANY DATA:	
		COMPANY CONFORMED NAME:			BIOANALYTICAL SYSTEMS INC
		CENTRAL INDEX KEY:			0000720154
		STANDARD INDUSTRIAL CLASSIFICATION:	SERVICES-COMMERCIAL PHYSICAL & BIOLOGICAL RESEARCH [8731]
		IRS NUMBER:				351345024
		STATE OF INCORPORATION:			IN
		FISCAL YEAR END:			0930

	FILING VALUES:
		FORM TYPE:		10-K/A
		SEC ACT:		1934 Act
		SEC FILE NUMBER:	000-23357
		FILM NUMBER:		041039875

	BUSINESS ADDRESS:	
		STREET 1:		2701 KENT AVE
		CITY:			WEST LAFAYETT
		STATE:			IN
		ZIP:			47906-1382
		BUSINESS PHONE:		3174634527

	MAIL ADDRESS:	
		STREET 1:		2701 KENT AVENUE
		CITY:			WEST LAFAYETTE
		STATE:			IN
		ZIP:			47906-1382
</SEC-HEADER>
<DOCUMENT>
<TYPE>10-K/A
<SEQUENCE>1
<FILENAME>bas10k.htm
<DESCRIPTION>BIOANALYTICAL SYSTEMS, INC. AMENDMENT TO 10-K
<TEXT>
<HTML>
<HEAD>
<Title>Bioanalytical Systems, Inc. - Form 10-K</title></head>
<BODY>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=4>
UNITED STATES<br>
SECURITIES AND EXCHANGE COMMISSION<br>
WASHINGTON, D.C. 20549</FONT></H1>

<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=4>
FORM 10-K/A<BR>
(Amendment No. 1)</FONT></H1>

<P><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
 (Mark One)<br>
<br>
[&nbsp;X&nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;ANNUAL  REPORT  PURSUANT TO SECTION 13 OR
15(d)     OF     THE      SECURITIES      EXCHANGE      ACT     OF      1934<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for   the   fiscal   year  ended
September 30, 2003.<br>
<br>
OR<br>
<br>
[&nbsp;&nbsp;&nbsp;&nbsp;]&nbsp;&nbsp;&nbsp;&nbsp;TRANSITION  REPORT PURSUANT TO
SECTION 13 OR 15(d) OF THE  SECURITIES  EXCHANGE ACT OF 1934<br>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;for the  transition period from <U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>
to<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>.
</font></p>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Commission File Number 000-23357<br>
<b><big>BIOANALYTICAL SYSTEMS, INC.</big></b><br>
(Exact name of the registrant as specified in its charter)<br>
</font></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>

<TR>
<TD valign=bottom align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>INDIANA</U></FONT></TD>

<TD valign=bottom align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>35-1345024</U></FONT>
</TD>
</TR>

<TR>
<TD valign=top align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(State or other jurisdiction of incorporation or organization)</FONT></TD>

<TD valign=top align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(I.R.S. Employer Identification No.)<br><br></FONT></TD>
</tr>

<TR>
<TD valign=bottom align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
2701 KENT AVENUE<br>
<U>WEST LAFAYETTE, INDIANA</U></FONT></TD>

<TD align=center valign=bottom width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>47906</U></FONT></TD>
</TR>

<TR>
<TD valign=top align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Address of principle executive offices)</FONT></TD>

<TD valign=top align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Zip Code)<br><br></FONT></TD>
</TR>

<TR>
<TD valign=bottom COLSPAN=2 align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=3>
<U>(765) 463-4527</U></FONT>
</TD>
</TR>

<TR>
<TD valign=top COLSPAN=2 align=center width=50%><FONT FACE="Times New Roman, Times, Serif" SIZE=1>
(Registrant's telephone number, including area code)</FONT></TD>
</TR>

</TABLE>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Securities     registered     pursuant     to     Section     12(b)    of    the
Act:&nbsp;&nbsp;&nbsp;None</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Securities     registered     pursuant     to     section     12(g)    of    the
Act:&nbsp;&nbsp;&nbsp;Common Shares</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Indicate by check mark whether the registrant (1) has filed all reports required
to be filed by Section 13 or 15(d) of the Securities Exchange Act of 1934 during
the  preceding 12 months (or for such  shorter  period that the  registrant  was
required  to file  such  reports),  and  (2) has  been  subject  to such  filing
requirements for the past 90 days.&nbsp;&nbsp;&nbsp;YES&nbsp;&nbsp;
<U>&nbsp;&nbsp;&nbsp;X&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
NO&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Indicate by check mark if disclosure of delinquent  filers  pursuant to Item 405
of Regulation  S-K is not contained  herein,  and will not be contained,  to the
best of registrant's  knowledge,  in definitive proxy or information  statements
incorporated by reference in Part III of this Form 10-K or any amendment to this
Form
10-K.&nbsp;&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Indicate  by check mark  whether  the  registrant  is an  accelerated  filer (as
defined              in              Rule              12b-2).&nbsp;&nbsp;&nbsp;
YES&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;</U>&nbsp;&nbsp;&nbsp;&nbsp;
&nbsp;NO&nbsp;&nbsp;<U>&nbsp;&nbsp;&nbsp;X&nbsp;&nbsp;&nbsp;</u></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Based on the closing price on the NASDAQ stock market on January 12, 2004,  the
aggregate  market  value of the  voting and  non-voting  common  equity  held by
non-affiliates  of the  registrant  is  $22,979,280.  As of January 12, 2004,
4,869,502 shares of registrant&#146;s common shares were outstanding.  No shares
of  registrant&#146;s  Preferred  Stock  were  outstanding  as of  January 12, 2004.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Portions of the following  documents  have been  incorporated  by reference into
this report:</font></P>

<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR>
<TD width=20%>&nbsp;</td>
<TD width=30%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Registrant's Document</U></font></td>
<TD width=30%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Parts Into Which Incorporated</U></font></td>
</tr>

<TR>
<TD>&nbsp;</td>
</TR>

<tr>
<TD width=20%>&nbsp;</td>
<TD valign=top width=30%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Annual Report to security<br> holders for the fiscal year<br>ended September 30, 2003<br></font></td>
<TD valign=top width=30%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Part II<br><br></font></td>
</tr>

<TR>
<TD>&nbsp;</td>
</TR>

<tr>
<TD width=20%>&nbsp;</td>
<TD valign=top width=30%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Proxy Statement</font></td>
<TD valign=top width=30%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Part III</font></td>
</TR>
</TABLE>

<PAGE>

<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" size=2>
Explanatory Note</font></P>
<BR>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; The Company is filing this
Amendment No. 1 to Annual Report on Form 10-K/A which was for the fiscal year
ended September 30, 2003, solely to revise the disclosures contained in Item 9A
of Part II of the Form 10-K filed with the Securities and Exchange Commission on
January 13, 2004. Except for the item noted above, no other information is being
amended by this Form 10-K/A. The Company has not updated disclosures in this
Form 10-K/A to reflect any event subsequent to the Company's filing of the
original Form 10-K.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
<B>Item 9A.&nbsp;&nbsp;&nbsp;&nbsp;Controls and Procedures.</B></font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
Based on their most recent evaluation, which was completed as of September 30,
2003, the Company's Chief Executive Officer and interim Chief Financial Officer
believe that, because of the situation described below, the Company's disclosure
controls and procedures (as defined in Exchange Act Rules 13a-15(e) and
15d-15(e)) were not effective as of September 30, 2003 in timely alerting the
Company's management to material information required to be included in this
Form 10-K and other Exchange Act filings. Upon completing their review, the
Chief Executive Officer and the interim Chief Financial Officer concluded that
the Company was not producing final versions of its Exchange Act reports
sufficiently early to allow the Chief Executive Officer to thoroughly review
them. Since September 30, 2003, the Company has shifted responsibility for the
preparation of the Exchange Act reports to different personnel, has formed a
Disclosure Committee to review its Exchange Act reports, has adopted a more
structured timetable for completing the required disclosure and has obtained
more extensive involvement by the Chief Executive Officer in the preparation of
the reports.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
Except as indicated below, there were no significant changes in the Company's
internal controls or other factors that could significantly affect those
controls subsequent to the date of their evaluation, which was completed as of
September 30, 2003.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
The Company&#146;s independent auditors have informed the audit committee that a
material weakness has been identified in the Company's internal control for the
year ended September 30, 2003. Specifically, the independent auditors noted that
the Company's internal control failed to timely alert management of potential
loan covenant noncompliance. The Company did not have procedures in place to
monitor near-term future financial position and results of operations to enable
it to take operational action in the event of potential loan covenant
noncompliance. The Company has taken measures to correct this material weakness
in the form of enhancing its planning process and creating procedures to more
timely identify credit agreement compliance issues.</font></P>

<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
The auditors also informed the Company of additional reportable conditions (as
the term &#147;reportable conditions&#148; is defined by the American Institute
of Certified Public Accountants) that required adjustments to fairly state the
Company&#146;s financial statements for the year ended September 30, 2003. These
conditions related to errors in the computation of earned revenues on long-term
contracts at two of the Company&#146;s locations, and an error in recognizing
income related to a pre-acquisition contract by one of the Company&#146;s
acquired businesses. The Company is in the process of implementing a new system
for managing contracts, that, among other things, applies better controls to
recording and tracking contracts, and automates the computation of earned
revenues. Until this new system is fully functional, additional review
procedures have been established. The Company's controller resigned on July 31,
2003, although she continued to work on a part-time basis through November 4,
2003, and the Chief Financial Officer resigned on October 31, 2003. Since these
resignations, the Company has appointed an interim Chief Financial Officer and
the Company is in the process of recruiting to fill these positions. The Company
has made interim arrangements with a consulting firm to provide the additional
necessary support needed while the search for a new controller and a new Chief
Financial Officer continues.</font></P>


<BR>
<BR>
<BR>
<P ALIGN=RIGHT><FONT FACE="Times New Roman, Times, Serif" size=1>
2</font></P>



<PAGE>


<!-- MARKER FORMAT-SHEET="Part Numbering" FSL="Workstation" -->
<H1 ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
SIGNATURES</FONT></H1>
<BR>

<!-- MARKER FORMAT-SHEET="Para Indent Lv 0-TNR" FSL="Default" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Pursuant to the requirements of Section 13 or 15(d) of the Securities Exchange
Act of 1934, the Registrant has duly caused this report to be signed on its
behalf by the undersigned, thereunto duly authorized.</FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=bottom>

<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Date:&nbsp;&nbsp;September 17, 2004<BR>
</FONT></TD>

<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
BIOANALYTICAL SYSTEMS, INC.<BR>
&nbsp;&nbsp;(Registrant)<BR>
<BR>
<BR>
By:&nbsp;&nbsp;/s/&nbsp;Peter T. Kissinger<hr>
Peter T. Kissinger<BR>
President, Chairman and Chief Executive Officer<BR>
<BR>
<BR>
<BR>
By:&nbsp;&nbsp;/s/&nbsp;Michael R. Cox<hr>
Michael R. Cox<BR>
Chief Financial Officer and<BR>
VP - Finance<BR>
</FONT></TD>
</TR>
</TABLE>
<BR>

<BR>
<BR>
<BR>
<P ALIGN=RIGHT><FONT FACE="Times New Roman, Times, Serif" size=1>
3</font></P>

<PAGE>



<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Pursuant to
the requirements of the Securities Exchange Act of 1934, this report has been
signed below by the following persons on behalf of the Registrant and in the
capacities and on the dates indicated.</FONT></P>
<BR>

<TABLE CELLPADDING=0 CELLSPACING=0 BORDER=0 ALIGN=Center WIDTH=100%>
<TR VALIGN=TOP>
     <TH align=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>Signature</U></FONT></TH>
     <TH align=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>Capacity</U></FONT></TH>
     <TH align=left><FONT FACE="Times New Roman, Times, Serif" SIZE=2><U>Date</U></FONT></TH></TR>


<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR VALIGN=TOP>
     <TD WIDTH=36% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>/s/&nbsp;Peter T. Kissinger<hr width=225>Peter T. Kissinger</FONT></TD>
     <TD WIDTH=40% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>President, Chairman and Chief<BR>Executive Officer and Director<BR>(Principal Executive Officer)</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>




<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>/s/&nbsp;Michael R. Cox<hr width=225>Michael R. Cox</FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Chief Financial Officer and <BR>VP - Finance<BR>(Principal Financial and Accounting Officer)</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>


<tr>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>/s/&nbsp;William E. Baitinger<hr width=225></FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Director</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>William E. Baitinger</FONT></TD></TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2><hr width=225></FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Director</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Leslie B. Daniels</FONT></TD></TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>


<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2><hr width=225></FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Director</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Gayl W. Doster</FONT></TD></TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>


<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>/s/&nbsp;Candice B. Kissinger<hr width=225></FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Director</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Candice B. Kissinger</FONT></TD></TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>


<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>/s/&nbsp;Ronald E. Shoup<hr width=225></FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Director</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Ronald E. Shoup</FONT></TD></TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>


<TR VALIGN=TOP>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2><hr width=225></FONT></TD>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>Director</FONT></TD>
     <TD WIDTH=16% ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>September 17, 2004</FONT></TD></TR>
<TR VALIGN=Bottom>
     <TD ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>W. Leigh Thompson</FONT></TD></TR>

<TR>
<TD>&nbsp;</td>
</TR>

<TR>
<TD>&nbsp;</td>
</TR>

</TABLE>




<BR>
<BR>
<BR>
<P ALIGN=RIGHT><FONT FACE="Times New Roman, Times, Serif" size=1>
4</font></P>

<PAGE>




<P align=justify><FONT FACE="Times New Roman, Times, Serif" size=2>
<B>INDEX TO EXHIBITS</B></font></P>
<BR>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE align=center WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=bottom>
<Th align=center WIDTH=15%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Number<BR>Assigned In<BR>Regulation S-K<BR><U>Item 601</U></FONT></Th>
<Th align=center WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</FONT></Th>
<Th WIDTH=85%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<U>Description of Exhibits</U></FONT></Th>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE align=center WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD align=center WIDTH=12%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(31)</FONT></TD>
<TD align=center WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
31.1</FONT></TD>
<TD WIDTH=65%><div align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Certification of Chief Executive Officer</FONT></div></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE align=center WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD align=center WIDTH=12%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</FONT></TD>
<TD align=center WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
31.2</FONT></TD>
<TD WIDTH=65%><div align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Certification of Chief Financial Officer</FONT></div></TD>
</TR>
</TABLE>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE align=center WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD align=center WIDTH=12%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
(32)</FONT></TD>
<TD align=center WIDTH=10%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=65%><div align=justify><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
Section 1350 Certifications</FONT></div></TD>
</tr>
</TABLE>
<BR>


<BR>
<BR>
<BR>
<P ALIGN=RIGHT><FONT FACE="Times New Roman, Times, Serif" size=1>
5</font></P>



</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>2
<FILENAME>exhibit311.htm
<DESCRIPTION>EXHIBIT 31.1
<TEXT>

<HTML>
<HEAD>
<TITLE>Exhibit 31.1</TITLE>
</HEAD>
<BODY>


<!-- MARKER FORMAT-SHEET="Head Left" FSL="Default" -->
<P ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>EXHIBIT 31.1</B> </FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Head Minor Center" FSL="Workstation" -->
<P ALIGN=CENTER><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>CERTIFICATIONS</B> </FONT></P>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
I, Peter T. Kissinger, Chief Executive Officer, certify that:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of
Bioanalytical Systems, Inc.;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Based on my knowledge, this annual report does not contain any untrue statement
          of a material fact or omit to state a material fact necessary to make the
          statement made, in light of the circumstances under which such statements were
          made, not misleading with respect to the period covered by this report;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Based on my knowledge, the financial statements, and other financial information
          included in this annual report, fairly present in all material respects the
          financial condition, results of operations and cash flows of the registrant as
          of, and for, the period presented in this report;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          The registrant&#146;s other certifying officer(s) and I are responsible for
          establishing and maintaining disclosure controls and procedures (as defined in
          Exchange Act Rules 13a-15(e) and 15d-15(e)) [clause omitted pursuant to SEC
          Release Nos. 33-8238 and 34-47986] for the registrant and have:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Designed such disclosure controls and procedures, or caused such disclosure
          controls and procedures to be designed under our supervision, to ensure that
          material information relating to the registrant, including its consolidated
          subsidiaries, is made known to us by others within those entities, particularly
          during the period in which this report is being prepared;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          [paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986];</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Evaluated the effectiveness of the registrant&#146;s disclosure controls and
          procedures and presented in this report our conclusions about the effectiveness
          of the disclosure controls and procedures, as of the end of the period covered
          by this report based on such evaluation; and</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Disclosed in this report any change in the registrant&#146;s internal control
          over financial reporting that occurred during the registrant&#146;s most recent
          fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an
          annual report) that has materially affected, or is reasonably likely to
          materially affect, the registrant&#146;s internal control over financial
          reporting; and</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          The registrant&#146;s other certifying officer(s) and I have disclosed, based on
          our most recent evaluation of internal control over financial reporting, to the
          registrant&#146;s auditors and the audit committee of the registrant&#146;s
          board of directors (or persons performing the equivalent functions):</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          All significant deficiencies and material weaknesses in the design or operation
          of internal control over financial reporting which are reasonably likely to
          adversely affect the registrant&#146;s ability to record, process, summarize and
          report financial information; and</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Default" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Any fraud, whether or not material, that involves management or other employees
          who have a significant role in the registrant&#146;s internal control over
          financial reporting.</FONT></P>
<BR>


<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
September 17, 2004</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/&nbsp;Peter T. Kissinger<hr>
Peter T. Kissinger<BR>
Chief Executive Officer<BR>
</FONT></TD>
</TR>
</TABLE>
<BR>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-31
<SEQUENCE>3
<FILENAME>exhibit312.htm
<DESCRIPTION>EXHIBIT 31.2
<TEXT>












<HTML>
<HEAD>
<TITLE>Exhibit 31.2 - Certification</TITLE>
</HEAD>
<BODY>


<!-- MARKER FORMAT-SHEET="Head Left" FSL="Workstation" -->
<P ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>EXHIBIT 31.2</B> </FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Workstation" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
I, Michael R. Cox, Chief Financial Officer and VP - Finance, certify
that:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;1.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
I have reviewed this Amendment No. 1 to Annual Report on Form 10-K/A of
Bioanalytical Systems, Inc.;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;2.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Based on my knowledge, this annual report does not contain any untrue statement
          of a material fact or omit to state a material fact necessary to make the
          statement made, in light of the circumstances under which such statements were
          made, not misleading with respect to the period covered by this report;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;3.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Based on my knowledge, the financial statements, and other financial information
          included in this annual report, fairly present in all material respects the
          financial condition, results of operations and cash flows of the registrant as
          of, and for, the period presented in this report;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;4.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          The registrant&#146;s other certifying officer(s) and I are responsible for
          establishing and maintaining disclosure controls and procedures (as defined in
          Exchange Act Rules 13a-15(e) and 15d-15(e)) [clause omitted pursuant to SEC
          Release Nos. 33-8238 and 34-47986] for the registrant and have:</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Designed such disclosure controls and procedures, or caused such disclosure
          controls and procedures to be designed under our supervision, to ensure that
          material information relating to the registrant, including its consolidated
          subsidiaries, is made known to us by others within those entities, particularly
          during the period in which this report is being prepared;</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          [paragraph omitted pursuant to SEC Release Nos. 33-8238 and 34-47986];</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(c)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Evaluated the effectiveness of the registrant&#146;s disclosure controls and
          procedures and presented in this report our conclusions about the effectiveness
          of the disclosure controls and procedures, as of the end of the period covered
          by this report based on such evaluation; and</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(d)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Disclosed in this report any change in the registrant&#146;s internal control
          over financial reporting that occurred during the registrant&#146;s most recent
          fiscal quarter (the registrant&#146;s fourth fiscal quarter in the case of an
          annual report) that has materially affected, or is reasonably likely to
          materially affect, the registrant&#146;s internal control over financial
          reporting; and</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;5.&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          The registrant&#146;s other certifying officer(s) and I have disclosed, based on
          our most recent evaluation of internal control over financial reporting, to the
          registrant&#146;s auditors and the audit committee of the registrant&#146;s
          board of directors (or persons performing the equivalent functions):</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Workstation" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(a)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          All significant deficiencies and material weaknesses in the design or operation
          of internal control over financial reporting which are reasonably likely to
          adversely affect the registrant&#146;s ability to record, process, summarize and
          report financial information; and</FONT></P>

<!-- MARKER FORMAT-SHEET="Para (List) Indent Lv 0- TNR" FSL="Default" -->
     <P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;(b)&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
          Any fraud, whether or not material, that involves management or other employees
          who have a significant role in the registrant&#146;s internal control over
          financial reporting.</FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
September 17, 2004</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/&nbsp;Michael R. Cox<HR>
Michael R. Cox<BR>
Chief Financial Officer and<BR>
VP - Finance</FONT></TD>
</TR>
</TABLE>
<BR>

</BODY>
</HTML>

</TEXT>
</DOCUMENT>
<DOCUMENT>
<TYPE>EX-32
<SEQUENCE>4
<FILENAME>exhibit32.htm
<DESCRIPTION>EXHIBIT 32
<TEXT>


<HTML>
<HEAD>
<TITLE>Exhibit 32</TITLE>
</HEAD>
<BODY>


<!-- MARKER FORMAT-SHEET="Head Left" FSL="Workstation" -->
<P ALIGN=LEFT><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
<B>Exhibit 32</B></FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
I, Peter T. Kissinger, the Chairman of the Board, President and Chief Executive
Officer of Bioanalytical Systems, Inc., certify that (i) Amendment No. 1 to
Annual Report on Form 10-K/A for the year ended September 30, 2003, (the
&#147;Report&#148;) fully complies with the requirements of Section 13(a) or
15(d) of the Securities Exchange Act of 1934, and (ii) the information contained
in the Report fairly presents, in all material respects, the financial condition
and results of operations of Bioanalytical Systems, Inc. as of the dates and for
the periods set forth therein.</FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>&nbsp;</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/&nbsp;Peter T. Kissinger<hr>
Peter T. Kissinger<BR>
Chairman of the Board,<BR>
President and<BR>
Chief Executive Officer<BR>
September 17, 2004</FONT></TD>
</TR>
</TABLE>
<BR>
<BR>

<!-- MARKER FORMAT-SHEET="Para Flush Lv 0-TNR" FSL="Default" -->
<P ALIGN=JUSTIFY><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
I, Michael R. Cox, the Chief Financial Officer and VP - Finance of Bioanalytical
Systems, Inc., certify that (i) Amendment No. 1 to Annual Report on Form
10-K/A for the year ended September 30, 2003, (the &#147;Report&#148;) fully
complies with the requirements of Section 13(a) or 15(d) of the Securities
Exchange Act of 1934, and (ii) the information contained in the Report fairly
presents, in all material respects, the financial condition and results of
operations of Bioanalytical Systems, Inc. as of the dates and for the periods
set forth therein.</FONT></P>
<BR>

<!-- MARKER FORMAT-SHEET="Signature Block w/Company Name" FSL="Workstation" -->
<TABLE WIDTH=100% CELLPADDING=0 CELLSPACING=0 BORDER=0>
<TR VALIGN=TOP>
<TD WIDTH=60%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
&nbsp;</FONT></TD>
<TD WIDTH=40%><FONT FACE="Times New Roman, Times, Serif" SIZE=2>
/s/&nbsp;Michael R. Cox<hR>
Michael R. Cox<BR>
Chief Financial Officer and<BR>
VP - Finance<BR>
September 17, 2004</FONT></TD>
</TR>
</TABLE>
<BR>


</BODY>
</HTML>

</TEXT>
</DOCUMENT>
</SEC-DOCUMENT>
-----END PRIVACY-ENHANCED MESSAGE-----
